Specify a stock or a cryptocurrency in the search bar to get a summary
Tibet Rhodiola Pharmaceutical Holding Co
600211Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China. Address: Lhasa Economic and Tech Dev Zn, Lhasa, China, 850000
Analytics
WallStreet Target Price
428.16 CNYP/E ratio
16.7293Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 600211
Dividend Analytics 600211
Dividend growth over 5 years
171 %Continuous growth
1 yearPayout Ratio 5 years average
38 %Dividend History 600211
Stock Valuation 600211
Financials 600211
Results | 2019 | Dynamics |